Cellworks is leading Precision Medicine in Oncology through personalized cancer therapy response predictions. Using innovative OMICs modeling, computational biosimulation and AI heuristics, Cellworks predicts the most efficacious therapies for patients. Cellworks goes beyond the current ‘one mutation, one drug’ paradigm by interpreting complete mutational downstream effects to provide actionable therapy predictions for physicians and patients. Join the Cellworks myCare clinical trials today.